Clinical screening assay for EGFR exon 19 mutations using PNA-clamp smart amplification process version 2 in lung adenocarcinoma.
Araki T, Shimizu K, Nakamura T, Baba M, Kawai Y, Nakamura K, Mitani Y, Obayashi K, Aomori T, Fujita Y, Miyamae Y, Kakegawa S, Kaira K, Lezhava A, Hayashizaki Y, Takeyoshi I, Yamamoto K.
Araki T, et al.
Oncol Rep. 2011 Nov;26(5):1213-9. doi: 10.3892/or.2011.1391. Epub 2011 Jul 15.
Oncol Rep. 2011.
PMID: 21769434